Beijing New Oriental Star Petrochemical Engineering Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 24.59%

Beijing New Oriental Star Petrochemical Engineering Co Ltd (002755) has an Asset Resilience Ratio of 24.59% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥1.09 Billion
≈ $159.60 Million USD Cash + Short-term Investments

Total Assets

CN¥4.44 Billion
≈ $649.16 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Beijing New Oriental Star Petrochemical Engineering Co Ltd's Asset Resilience Ratio has changed over time. Check Beijing New Oriental Star Petrochemical strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Beijing New Oriental Star Petrochemical Engineering Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002755 market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.09 Billion 24.59%
Total Liquid Assets CN¥1.09 Billion 24.59%

Asset Resilience Insights

  • Good Liquidity Position: Beijing New Oriental Star Petrochemical Engineering Co Ltd maintains a healthy 24.59% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Beijing New Oriental Star Petrochemical Engineering Co Ltd Industry Peers by Asset Resilience Ratio

Compare Beijing New Oriental Star Petrochemical Engineering Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621
Drug Manufacturers - Specialty & Generic 2.04%
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390
Drug Manufacturers - Specialty & Generic 0.01%
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
Drug Manufacturers - Specialty & Generic 7.85%
Jw Pharmac
KO:001060
Drug Manufacturers - Specialty & Generic 3.65%
Kamada
TA:KMDA
Drug Manufacturers - Specialty & Generic 0.00%
Samjin Pharm
KO:005500
Drug Manufacturers - Specialty & Generic 0.25%

Annual Asset Resilience Ratio for Beijing New Oriental Star Petrochemical Engineering Co Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Beijing New Oriental Star Petrochemical Engineering Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 16.88% CN¥683.28 Million
≈ $99.99 Million
CN¥4.05 Billion
≈ $592.30 Million
-3.38pp
2023-12-31 20.26% CN¥713.83 Million
≈ $104.46 Million
CN¥3.52 Billion
≈ $515.65 Million
-4.32pp
2022-12-31 24.57% CN¥839.08 Million
≈ $122.78 Million
CN¥3.41 Billion
≈ $499.63 Million
+10.55pp
2021-12-31 14.02% CN¥522.39 Million
≈ $76.44 Million
CN¥3.72 Billion
≈ $545.05 Million
+11.40pp
2020-12-31 2.63% CN¥100.00 Million
≈ $14.63 Million
CN¥3.81 Billion
≈ $557.24 Million
-0.08pp
2019-12-31 2.71% CN¥100.00 Million
≈ $14.63 Million
CN¥3.69 Billion
≈ $540.27 Million
+1.69pp
2018-12-31 1.01% CN¥30.00 Million
≈ $4.39 Million
CN¥2.96 Billion
≈ $432.89 Million
-79.94pp
2015-12-31 80.96% CN¥580.00 Million
≈ $84.87 Million
CN¥716.42 Million
≈ $104.84 Million
--
pp = percentage points

About Beijing New Oriental Star Petrochemical Engineering Co Ltd

SHE:002755 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.81 Billion
CN¥12.37 Billion CNY
Market Cap Rank
#6439 Global
#1279 in China
Share Price
CN¥13.33
Change (1 day)
+2.22%
52-Week Range
CN¥12.50 - CN¥28.15
All Time High
CN¥38.01
About

Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is bas… Read more